ClinConnect ClinConnect Logo
Search / Trial NCT06038409

Ketamine Treatment Plans for Chronic Conditions

Launched by RIVER FOUNDATION · Sep 7, 2023

Trial Information

Current as of June 18, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how effective different ways of using ketamine are for treating chronic conditions like chronic pain, depression, anxiety, and other long-term health issues. Ketamine is a medication that is often used off-label, which means it’s used in ways not officially approved by health authorities. The study wants to understand how well ketamine works for people who are already receiving this treatment for their chronic conditions.

If you or a loved one are between the ages of 65 and 74 and have a diagnosed chronic condition, you might be eligible to participate in this study. However, healthy individuals without a chronic condition cannot join. Participants can expect to receive ketamine as part of their treatment plan and will help researchers learn more about its effectiveness. It’s important to know that this study is currently recruiting, so there is an opportunity to take part in this important research aimed at improving care for chronic conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Must have an identifiable chronic condition.
  • Exclusion Criteria:
  • Healthy population

About River Foundation

River Foundation is a dedicated clinical research organization committed to advancing healthcare through innovative research and development. With a focus on fostering partnerships in the medical community, River Foundation conducts rigorous clinical trials aimed at evaluating new therapies and treatment modalities. The organization prioritizes patient safety and ethical standards while striving to enhance the quality of life for individuals affected by various health conditions. Through its collaborative approach and commitment to scientific integrity, River Foundation plays a pivotal role in translating research findings into meaningful healthcare solutions.

Locations

Helena, Montana, United States

Patients applied

0 patients applied

Trial Officials

Edward Lesofski, MS

Study Director

RIVER Foundation

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported